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ABSTRACT
Objectives: To examine the attitudes of UK healthcare
professionals towards what they believe constitutes
specialist care for teenage and young adult (TYA) patients
with cancer, to determine which factors they considered
to be the most important components of specialist TYA
care, and whether opinion varied between clinical
specialties and reflected the drivers for care improvements
within National Health Service (NHS) policy.
Design and methods: The study utilised a cross-
sectional survey, using Likert scales, to assess attitudes
towards specialist care. Responses were grouped using
model-based clustering methods implemented in
LatentGold 4.5.
Setting: Participants from 98 NHS trusts in the UK were
invited to participate in the study.
Participants: 691 healthcare professionals involved in
the management of TYA patients were approached; of
these, 338 responded.
Results: 338 healthcare professionals responded (51.9%
of those invited). Responses were grouped into three
clusters according to the pattern of responses to the
questions. One cluster rated age-appropriate care above
all else, the second rated both age and site-appropriate
care highly while the third assigned more importance to
site-specific care. Overall, the psychosocial and supportive
aspects of care were rated highest while statements
relating to factors known to be important (access to
clinical trials, treatment at a high volume centre and
specialist diagnostics) were not rated as highly as
expected.
Conclusions: Attitudes varied widely between
professionals treating TYA patients with cancer as to what
constitutes key aspects of specialist care. Further work is
needed to quantify the extent to which this influences
practice.
INTRODUCTION
The incidence of cancer in teenagers and
young adults (TYA) is rare compared with
that in older adults.1 In recent years, only
around 2000 cases have been diagnosed
annually in patients aged between 15 and
24;1 2 thus, its optimal management poses a
major challenge to healthcare providers.
Challenges include not only the wide spec-
trum of cancers experienced by this age
group but also the host and disease biology
of these tumours, which can differ from that
seen in both children and adults.3–6
Likewise, individuals in this age group also
have very different psychosocial needs to
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▪ Further work would allow for responses from a
wider study population and more in-depth exam-
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either adults or children.7–9 The optimal setting to meet
these biological and psychosocial needs is, therefore, not
ideally managed by adult or children’s cancer teams, but
by a TYA-specialist team drawing expertise from both
professional groups. The widely varying spectrum of
cancers affecting this age group and their unusual pos-
ition in terms of age-focused services has led many to
argue in favour of specialist care.10–12 However, owing to
the different age-speciﬁc and cancer-speciﬁc care needs
involved, there is, as yet, no consensus on what constitu-
tes such ‘specialist’ care.10 12–14
Access to tumour-specialist multidisciplinary teams
(MDTs), age-specialist MDTs and specialist diagnostic ser-
vices, clinical trials and specialist supportive services have
all been cited as crucial to optimal outcomes in tumour
site-speciﬁc guidelines (National Institute for Health and
Clinical Excellence cancer service guidelines11). Other
guidelines place more emphasis on the importance of
age-speciﬁc services and the availability of psychosocial
and late effects supportive care.15 Principal treatment
centres (PTC) have been advocated where patients have
access to specialist environments of care, as were appro-
priately trained professionals from both site-speciﬁc and
age-speciﬁc teams working together closely. A larger
degree of specialisation than other cancer units has been
supported. Three different types of PTC exist with three
different foci: TYA-speciﬁc (teenage cancer trust (TCT)
unit),16 paediatric (Children’s Cancer and Leukaemia
Group (CCLG) unit)17 and cancer site-speciﬁc units.18 In
some cases, a single centre may include all three types of
specialist units.
There is known variation in where, how and by whom
TYA patients with cancer are treated.19 20 What is not
fully understood is whether this is due to the availability
of services (both geographically and age wise), patient’s
choice or physician’s decision. Understanding the atti-
tudes of those who treat this age range is vital to gaining
a clearer insight into the key components of care of this
age group, and therefore determining to what extent
varying attitudes may be inﬂuencing the variation in
treatment.
Policy states that treatment at a PTC is a key part of the
cancer treatment pathway, as is access to clinical trials,
MDT follow-up, age and cancer site appropriate care.11
The latter has not been examined in detail, and therefore
this study aimed to examine the variation in attitudes
towards specialist care for TYA patients among those
involved in the treatment of this group, and to determine
whether opinion mirrored policy. It also aimed to quan-
tify any variation noted and to establish whether this was
associated with speciﬁc characteristics of the respondents
such as job title, type of centre and caseload.
PARTICIPANTS AND METHODS
Sample selection
A list of healthcare professionals from National Health
Service (NHS) trusts across the UK (England, Scotland,
Wales and Northern Ireland) involved in the treatment
of TYA patients were identiﬁed using NHS trust websites.
Individuals, including doctors, nurses and other health
professionals, such as radiographers and physiothera-
pists, with a specialty which involved the care of patients
with cancer and whose contact details were available on
the NHS trust website, were included. Email addresses
were freely available for 98 trusts in the UK at the time
of this study. Each individual was contacted by email
during June 2009 and asked to complete the question-
naire and to forward it to others to whom it might have
been of interest. Non-responders received two follow-up
emails between December 2009 and February 2010.
Survey development and study protocol
The survey consisted of a list of statements (table 1)
about factors that had been identiﬁed in the medical lit-
erature as being potentially important features of spe-
cialist TYA cancer care.10 12 19 21–25 The statements
encompassed both age-appropriate and site-speciﬁc fea-
tures of care alongside more general aspects of cancer
services. Respondents were asked to rate these 27 state-
ments using a Likert scale (1—low importance to 5—
high importance). Questions regarding the age range
that respondents deemed appropriate for TYA patients,
respondent’s specialty and afﬁliation with a TCT unit
were also included.
Statistical analysis
Descriptive statistics were used to describe demographics
of respondents. Mann-Whitney tests were used to
examine the difference between demographic informa-
tion and the responses on the 5-point Likert scale.
Missing information was recorded as such in the ana-
lysis, as the proportion of respondents who left each
question blank was considered an interesting outcome
in its own right.
Model-based latent cluster analysis was used to estab-
lish underlying characteristics and relationships that
could be used to group data into natural/latent classes.
The Bayesian information criterion score was used to
determine the number of latent classes which provided
the best ﬁt to the respondents’ data. The analysis was
performed using Stata 11 and Latent Gold 4.5.27
RESULTS
Six hundred and ninety-one healthcare professionals
from 98 NHS trusts were asked to complete the ques-
tionnaire and 338 (51.9%) responded. The characteris-
tics of the respondents are detailed in table 2. In all, 253
(74.9%) were from England, 21 (6.2%) from Northern
Ireland, 30 (8.9%) from Scotland and 34 (10.1%) from
Wales. One hundred and ninety (56.2%) reported that
they were afﬁliated with a teenage cancer unit and 208
(61.5%) were linked to a CCLG unit. The majority of
respondents belonged to a medical rather than a surgi-
cal specialism (78.4% vs 21.6%, respectively). Over half
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of all those who responded (55.7%) reported that less
than 10% of their annual workload comprised TYA
patients and only 35 respondents (16.8%) reported
seeing more than 20 TYA oncology patients annually. In
total, 129 respondents (38.2%) failed to report the
number of TYA patients treated annually; however, only
2 (0.6%) failed to report the proportion of their total
caseload which consisted of TYA patients. The most fre-
quently suggested lower age range for a TYA service was
13 (52.7%, range 11–19 years of age) and the most
commonly (modal) recommended upper age limit was
25 (25.7%, range 16–40 years of age).
Many respondents also recorded that the patient
range should not be restricted by age but by the diagnos-
tic group and emotional maturity of the patient. The
latent class model identiﬁed three clusters of respon-
dents with speciﬁc attitudes concerning specialist care
(ﬁgure 1).
Cluster 3 rated the treatment by a site-speciﬁc team
higher than an age-specialist team, but did not rate any
Table 1 Responses
Rank Q
4 or
higher 3
2 or
lower Missing
Questionn % n % n % n %
1 16 314 92.9 10 3.0 8 2.4 6 1.8 Psychological and psychosocial support from those
specialising in the care of teenagers and young adults.
2 14 314 92.9 11 3.3 8 2.4 5 1.5 Contact with a nurse specialising in the care of teenagers and
young adults.
3 13 303 89.6 18 5.3 13 3.8 4 1.2 Treatment in an age-appropriate environment.
4 1 289 85.5 32 9.5 13 3.8 4 1.2 Treatment by a site-specific surgical or medical team.
5 12 286 84.6 34 10.1 13 3.8 5 1.5 Access to age-appropriate clinical trials.
6 21 285 84.3 32 9.5 18 5.3 3 0.9 Contact with peers who have undergone or are undergoing
similar treatments or who have been diagnosed with the same
illness.
7 6 285 84.3 38 11.2 10 3.0 5 1.5 Regular follow-up by a site-specific MDT.
8 5 285 84.3 40 11.8 6 1.8 7 2.1 Contact with a site-specific clinical nurse specialist or
Macmillan nurse.
9 3 284 84.0 39 11.5 12 3.6 3 0.9 Access to site-specific clinical trials.
10 2 282 83.4 39 11.5 13 3.8 4 1.2 Diagnostics and staging by site-specialist clinical teams
(radiology, pathology, etc)
11 10 256 75.7 44 13.0 34 10.1 4 1.2 Treatment by a medical or surgical team who specialise in the
treatment and care of teenagers and young adults.
12 15 236 69.8 57 16.9 39 11.5 6 1.8 Regular follow-up by an age-specific MDT.
13 19 230 68.0 74 21.9 27 8.0 7 2.1 Treatment at a high volume cancer centre.
14 11 195 57.7 86 25.4 52 15.4 5 1.5 Diagnostics and staging by clinical teams specialising in the
care of teenagers and young adults (radiology, pathology, etc).
15 7 194 57.4 10 3.0 6 1.8 128 37.9 Psychological and psychosocial support from those
specialising in the care of persons with cancer.
16 26 192 56.8 10 3.0 3 0.9 133 39.3 Access to fertility specialists and advice on reproductive
issues.
17 17 188 55.6 12 3.6 5 1.5 133 39.3 Access to age-appropriate palliative care if needed.
18 24 186 55.0 16 4.7 4 1.2 132 39.1 Support for family friends and partners of the patient.
19 18 184 54.4 15 4.4 7 2.1 132 39.1 Access to age-appropriate end of treatment care and support
and information on late effects of treatment.
20 23 183 54.1 18 5.3 5 1.5 132 39.1 Educational and employment support during and after
treatment.
21 27 179 53.0 17 5.0 9 2.7 133 39.3 Ability to stay in contact with peers when in hospital,
Facebook, email text messages, etc
22 9 168 49.7 28 8.3 13 3.8 129 38.2 Access to site-specific end of treatment care and support and
information on late effects of treatment.
23 25 167 49.4 30 8.9 10 3.0 131 38.8 Treatment by the same team throughout.
24 8 160 47.3 30 8.9 17 5.0 131 38.8 Access to site-specific palliative care if needed.
25 22 141 41.7 43 12.7 22 6.5 132 39.1 Outpatient appointments held in an age-appropriate
environment.
26 20 129 38.2 116 34.3 86 25.4 7 2.1 Treatment at a hospital in close proximity to a patient’s home
address.
27 4 114 33.7 90 26.6 128 37.9 6 1.8 Inpatient treatment on a site-specific ward (eg, breast).
MDT,multidisciplinary team.
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Table 2 Characteristics of respondents
Cluster 1 Cluster 2 Cluster 3
Totaln % n % n %
Country
England 100 34.0 107 36.4 87 29.6 294
Scotland 6 40.0 5 33.3 4 26.7 15
Wales 5 27.8 9 50.0 4 22.2 18
Northern Ireland 3 27.3 3 27.3 5 45.5 11
Self-reported job title
Doctor 99 42.3 69 29.5 66 28.2 234
Nurse 9 14.1 36 56.3 19 29.7 64
Radiographer 1 10.0 1 10.0 8 80.0 10
Management 1 14.3 3 42.9 3 42.9 7
Social worker 0 0.0 3 60.0 2 40.0 5
Other 4 23.5 11 64.7 2 11.8 17
Unknown 0 0.0 1 100.0 0 0.0 1
Specialism
Medical 92 33.9 103 38.0 76 28.0 271
Surgical 22 32.8 21 31.3 24 35.8 67
Area of expertise
Oncology 38 26.8 57 40.1 47 33.1 142
Haematology 27 60.0 13 28.9 5 11.1 45
Paediatrics 10 55.6 1 5.6 7 38.9 18
Gynaecology 2 11.1 10 55.6 6 33.3 18
ENT 8 50.0 6 37.5 2 12.5 16
Palliative medicine 4 26.7 10 66.7 1 6.7 15
General surgery 3 21.4 4 28.6 7 50.0 14
Radiology 0 0.0 3 30.0 7 70.0 10
Other surgical specialty 18 35.0 2 15.0 15 45.0 35
Other non-surgical specialty 6 42.9 5 35.7 4 21.4 15
Other 6 42.9 14 35.7 6 21.4 26
Type of specialist interest
Age 9 18.4 15 30.6 25 51.0 49
Site 79 39.3 72 35.8 50 24.9 201
Both 26 29.9 36 41.4 25 28.7 87
Unknown 0 0.0 1 100.0 0 0.0 1
Teenage cancer unit
Yes 58 30.5 83 43.7 49 25.8 190
No 56 37.8 41 27.7 51 34.5 148
CCLG unit
Yes 70 33.7 70 33.7 68 32.7 208
No 44 33.8 54 41.5 32 24.6 130
Number of TYA patients seen annually
0–5 43 44.3 28 28.9 26 26.8 97
6–10 25 52.1 10 20.8 13 27.1 48
11–15 3 16.7 8 44.4 7 38.9 18
16–20 3 27.3 5 45.5 3 27.3 11
21+ 3 8.6 17 48.6 15 42.9 35
Unknown 37 28.7 56 43.4 36 27.9 129
Proportion of overall caseload consisting of TYA
Less than 10% 87 46.3 47 25.0 54 28.7 188
10–20% 14 26.9 23 44.2 15 28.8 52
20–30% 6 19.4 11 35.5 14 45.2 31
30–40% 4 26.7 9 60.0 2 13.3 15
Greater than 40% 3 6.0 32 64.0 15 30.0 50
Unknown 0 0.0 2 100.0 0 0.0 2
Total
114 33.7 124 36.7 100 29.6 338
CCLG, Children’s Cancer and Leukaemia Group; TYA, teenage and young adult.
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of the statements as highly as clusters 1 and 2, indicating
that individuals in cluster 3 answered more questions as
being of neither high nor low importance.
Cluster 1 rated age-appropriate treatment very highly
in all areas while cluster 2 rated most points highly and
did not favour either age-specialist or site-specialist care.
Overall, it appeared that clusters should be grouped as
follows:
Cluster 1—Age-speciﬁc preference
Cluster 2—Combined age-speciﬁc and site-speciﬁc preference
Cluster 3—Cancer site-speciﬁc preference
The variation in responses between the three clusters
was statistically signiﬁcant for all questions (p≤0.01),
with the exception of question 20 (p=0.61).
On further examination of the self-reported interests of
the respondents (table 2), the distribution of those
afﬁliated with a TCT or a CCLG unit was found to be
even across the three clusters. The majority of individuals
in cluster 3, which favoured site-specialist treatment, had
a site-speciﬁc interest (eg, colorectal or breast surgery),
and contained a greater proportion of those with a surgi-
cal specialty than any other cluster. Persons within cluster
2 treated the highest number of TYA cases annually,
while cluster 1 treated the lowest, with 68 respondents
reporting seeing fewer than 11 cases annually.
When the questions were ranked in order of import-
ance, the three questions ranked mostly highly were
(table 1): (1) psychological and psychosocial support
from those specialising in the care of TYA (314 respon-
dents (92.9%) marked as a 4 or higher); (2) contact with
a nurse specialising in the care of TYA (314 respondents
(92.9%) marked as a 4 or higher); and (3) treatment in
an age-appropriate environment (303 respondents
(89.6%) marked as a 4 or higher). The three statements
ranked the lowest were: (1) inpatient treatment on a site-
speciﬁc ward (eg, breast) (128 respondents (37.9%)
marked as a 2 or lower); (2) treatment at a hospital
in close proximity to a patient’s home address
(86 respondents (25.4%) marked as a 2 or lower); and
(3) diagnostics and staging by clinical teams specialising
in the care of teenagers and young adults (radiology,
pathology, etc) (52 respondents (15.4% marked as a 2 or
lower). The three statements which ranked the lowest
also had the greatest number of indifferent responses
(scored 3 on the Likert scale). Aspects of care often dis-
cussed as being key aspects of specialist care for TYA
patients by patients themselves 8 ranked relatively low on
the scale. Access to clinical trials, particularly site-speciﬁc,
ranked around the middle of the table of ordered
responses (ranked ninth most important). Treatment at a
high volume cancer centre was also ranked of relatively
low importance with only 230 respondents (68.0%)
scoring this 4 or higher and 74 (21.9%) recording it as
neither of high nor low importance.
Statements ranked 15th to 25th overall were
unanswered in over 35% of cases. These questions
related mainly to psychosocial support, palliative care
and long-term follow-up. This was vastly different to the
number of missing answers for other questions (range
3–7 missing answers). The focus of these questions may
have led a greater proportion of respondents to leave
them unanswered; previous studies have shown a patchy
and irregular referral to supportive services, suggesting a
greater degree of indifference than shown in the other
areas addressed in the study.27 28
DISCUSSION
This study demonstrates widely varying opinions as to
what is important in the care of TYA patients with
cancer. Attitudes were divided into three categories:
those who advocated age-appropriate care, those who
preferred tumour-site-specialist care and those who pro-
moted a combination of both age-specialist and site-
specialist care. The characteristics of individuals in these
three clusters were different, with specialism, caseload
Figure 1 Cluster analysis of
responses to the survey.
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and involvement with either a TYA or a CCLG unit
varying between groups. Aspects of care which are fre-
quently the focus of policy, such as access to a high
volume cancer centre and access to clinical trials, were
assigned lower importance than expected, as were all
aspects related to end of life care.
Current policy states that all patients in the TYA age
range should at least be offered the opportunity to be
treated at a PTC and to receive specialist care.11 This
study reﬂects the varying attitudes towards specialist care
for this age group and illustrates the difﬁculties in fully
implementing policy in relation to the differing degrees
of importance associated to it. Where the rhetoric is not
believed by all those involved in the diagnostic, treat-
ment and support pathway for this patient group, and as
long as ﬂexibility remains, specialist TYA cancer care,
as it is currently deﬁned, will not be implemented
consistently.
As a relatively young area of cancer treatment with a
multitude of diagnoses and treatment options, the path-
ways and protocols for TYA cancer care are known to
vary. Not all TYA patients are treated at TYA specialist
units; in some cases, this may be due to patient choice,
while in others it could be due to a lack of appropriate
referral to the units. This variation alongside the dis-
agreement as to what constitutes the key aspects of care
for TYA with cancer may demonstrate the need for
multidisciplinary involvement in order to ensure that
patients receive the best of all elements of care. All the
respondents to this survey were actively involved in the
treatment of TYA patients but have extremely divergent
views as to what constitutes ‘specialist’ care; this may go
some way to explain why there is variation in how and
where many TYA patients are treated. A preference
towards one type of care, age or site over another may
lead to an increased likelihood of favouring that care
setting and a decreased chance of utilisation of other
available services.
Wider implications
This study did not ask respondents whether their atti-
tudes to specialist care would inﬂuence their practice
but instead focused on the importance assigned to indi-
vidual aspects of care in the wider picture. In an area
such as TYA cancer care, where policy implementation is
known to vary by geography and patient demographics,
there is a degree of ﬂexibility in terms of patient path-
ways. The attitude of professionals involved at each stage
of the patient’s journey is likely to at least partly inﬂu-
ence the choices made. Unfortunately, in this case it was
not possible to assess the extent to which the inﬂuence
of clinicians varies at different points in the diagnostic
and treatment pathways. Understanding the range and
strength of opinions is vital before attempting to deter-
mine to what extent it inﬂuences practice. Policy states
that patients should be reviewed by both a TYA and a
site-speciﬁc MDT, emphasising that these should not be
considered mutually exclusive.
Limitations
This is the ﬁrst study to examine attitudes towards spe-
cialist cancer care in this age group. The method of
recruitment to the study (random sampling) may have
introduced bias, with those treating a high volume of
TYA patients, and those belonging to a medical specialty,
being more likely to reply than others. It is not possible
to address this issue in a random sample study of this
nature; however, the self-reported caseload ﬁgures and
distribution of medical staff across the clusters (table 2)
suggest that this has not been a signiﬁcant problem. A
similar issue was also identiﬁed regarding the proportion
of respondents who identiﬁed an afﬁliation with a
CCLG unit, which may have been due to the relatively
large number of centres in comparison to TCT centres
at the time of the study. Respondents were asked to iden-
tify any association between themselves and a specialist
unit, including occasional contact, so this does not
necessarily mean that this will have resulted in bias in
the results.
A large proportion of questions regarding psychosocial
support were unanswered; the reasoning behind this is
not understood and, owing to the nature of the survey
(Likert scale), it was not possible to investigate this in
more detail. Additional work could be performed to
address this using a more detailed survey assessing these
aspects of care.
This study was undertaken in 2009, 5 years after the
release of the Improving Outcomes Guidelines, and
therefore will be reﬂective of attitudes to specialist care
after the service redesign. Attitudes are likely to have
altered since the survey was undertaken; however, the
greatest degree of change is likely to have taken place
relatively quickly after the publication of the guidance.
In order to quantify any further changes in opinion, the
study could be performed again, using a similar cohort.
Further work is also now needed to assess to what
extent the attitudes of those treating TYA patients with
cancer inﬂuence their practice, including an analysis of
the attitudes of those referring patients for treatment
and an assessment of the degree of variation between
NHS trusts and cancer networks. In order to assess the
different inﬂuences which may be affecting the variation
in attitudes, such as proximity to a specialist centre and
duration of association with a PTC, greater detail regard-
ing the location and afﬁliation of the respondents would
be sought and analysed. Additional work to determine
any association between attitude and patient decision-
making and variation in attitudes and patient outcomes
would also add more detail to the understanding of a
complex area.
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